Chang, F., Bradley, L., & Swenson, R. (2001). Evaluation of the hydrogen bonding interactions and their effects on the oxidation-reduction potentials for the riboflavin complex of the Desulfovibrio vulgaris flavodoxin. Biochimica et Biophysica Acta, 1504(2-3), 319-28. https://doi.org/10.1016/s0005-2728(00)00260-7 (Original work published 2001)

Bradley, L., Paullus, W., Howe, J., & Litofsky, N. (2008). Isolated transverse process fractures: spine service management not needed. The Journal of Trauma, 65(4), 832-6; discussion 836. https://doi.org/10.1097/TA.0b013e318184d30e

Bradley, L., Wei, Y., Thumfort, P., Wurth, C., & Hecht, M. Protein design by binary patterning of polar and nonpolar amino acids. Methods in Molecular Biology (Clifton, N.J.), 352, 155-66. https://doi.org/10.1385/1-59745-187-8:155 (Original work published 2007)

Bradley, L., Thumfort, P., & Hecht, M. De novo proteins from binary-patterned combinatorial libraries. Methods in Molecular Biology (Clifton, N.J.), 340, 53-69. https://doi.org/10.1385/1-59745-116-9:53 (Original work published 2006)

Bradley, L., Kleiner, R., Wang, A., Hecht, M., & Wood, D. (2005). An intein-based genetic selection allows the construction of a high-quality library of binary patterned de novo protein sequences. Protein Engineering, Design & Selection : PEDS, 18(4), 201-7. https://doi.org/10.1093/protein/gzi020

Hecht, M., Das, A., Go, A., Bradley, L., & Wei, Y. (2004). De novo proteins from designed combinatorial libraries. Protein Science : A Publication of the Protein Society, 13(7), 1711-23. https://doi.org/10.1110/ps.04690804

Bradley, L., & Swenson, R. (2001). Role of hydrogen bonding interactions to N(3)H of the flavin mononucleotide cofactor in the modulation of the redox potentials of the Clostridium beijerinckii flavodoxin. Biochemistry, 40(30), 8686-95. https://doi.org/10.1021/bi010571j (Original work published 2001)

Bradley, L., Derr, B., Durbin, C., Lauer, M., Williams, F., Sinai, A., … Mohr-Schroeder, M. STEM Through Authentic Research and Training Program (START) for Underrepresented Communities: Adapting to the COVID-19 Pandemic. Journal of STEM Outreach, 4(4). https://doi.org/10.15695/jstem/v4i4.01 (Original work published 2021)

Gash, D., Gerhardt, G., Bradley, L., Wagner, R., & Slevin, J. (2020). GDNF clinical trials for Parkinson’s disease: a critical human dimension. Cell and Tissue Research, 382(1), 65-70. https://doi.org/10.1007/s00441-020-03269-8

Grondin, R., Littrell, O., Zhang, Z., Ai, Y., Huettl, P., Pomerleau, F., … Gerhardt, G. (2019). GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution. Neuropharmacology, 147, 28-36. https://doi.org/10.1016/j.neuropharm.2018.05.014 (Original work published 2019)